Recon: FDA approves Insmed’s chronic lung disease drug; Sanofi halts supply of cholesterol drug to China due to supply constraints
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States